- Udyam number
- UDYAM-HR-18-0023878

Avalon Medicines Private Limited
About Avalon Medicines Private Limited
Data last updated:
Avalon Medicines Private Limited is a private limited company based in Sonipat, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 01 November 2022.
The company is registered with the Registrar of Companies (ROC), Haryana, under CIN U24239HR2022PTC107489.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹2 Cr. It is led by directors Nitin Chhikara and Sanjeet Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 119 Sector 15, Sonipat, Haryana, India – 131001.
As per the financials filed for FY 2025, the company reported a revenue of ₹14.62 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.71 Cr (net margin -11.7%) and EBITDA of -₹24 Lakh (EBITDA margin -1.6%).
As per MCA filings, the company has open charges of ₹4 Cr on record.
Avalon Medicines Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-HR-18-0023878). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Recognitions & Rankings of Avalon Medicines
Contact details
Avalon Medicines Private Limited's registered office is in Sonipat, Haryana.
- Registered Address119 Sector 15, Sonipat, Haryana, India – 131001
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Avalon Medicines is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Avalon Medicines Private Limited, buy the company report.
Financials of Avalon Medicines Private Limited
FY 2025 filings availableAvalon Medicines Private Limited reported revenue of ₹14.62 Cr (up 157% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 157% in the latest year. EBITDA fell 267% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | -₹24 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹1.71 Cr | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | -1.6% | ||
| Net Profit Margin | -11.7% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Avalon Medicines Private Limited, buy the company report.
Board of directors of Avalon Medicines Private Limited
Avalon Medicines has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nitin Chhikara | Director | 13 May 2024 | 2 Years 6 Months | Current |
| Sanjeet Kumar Also directs: Synaxo Healthcare Private Limited | Director | 13 Sep 2024 | 2 Years 2 Months | Current |
Peer comparison
Avalon Medicines Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Fair Ford Pharmaceuticals Private Limited | ₹15.5 Cr (FY 2025) | 112.0% | Faridabad, Haryana, India | |||
| Gomti Research and Pharmachem Private Limited | ₹15.27 Cr (FY 2024) | 16.0% | Bangalore, Karnataka, India | |||
| Fine Processors Private Limited | ₹15.24 Cr (FY 2025) | 62.0% | New Delhi, Delhi, India | |||
| Jahnavi Chem Products Private Limited | ₹14.93 Cr (FY 2025) | 42.0% | Vijayawada, Andhra Pradesh, India | |||
| Emma Trading House India Private Limited | ₹14.63 Cr (FY 2025) | Thrissur, Kerala, India | ||||
| Avalon Medicines Private Limitedthis company | ₹14.62 Cr (FY 2025) | -₹1.71 Cr | -11.7% | 157.0% | Sonipat, Haryana, India | |
| J P Laboratories Private Limited | ₹14.54 Cr (FY 2025) | -1.0% | Pune, Maharashtra, India | |||
| Iza Pharmaceuticals Private Limited | ₹14.44 Cr (FY 2025) | 21.0% | Kozhikode, Kerala, India | |||
| Keewel Healthcare Private Limited | ₹14.04 Cr (FY 2025) | 18.0% | Thane, Maharashtra, India | |||
| Sri SPR Biologics Private Limited | ₹13.53 Cr (FY 2024) | -21.0% | Macherla, Andhra Pradesh, India | |||
| Alok Pharmaceutical and Industrial Co Pvt Ltd | ₹13.41 Cr (FY 2025) | -1.0% | Delhi, India |
To see the full peer comparison of Avalon Medicines Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Mar 2023 | 100691191 | Others | ₹4 Cr | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Avalon Medicines Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avalon Medicines Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Avalon Medicines Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Avalon Medicines Private Limited has 5 board changes on record since 2024: 2 appointments and 3 cessations. The latest: Aayush Gupta ceased to be Director on 18 Sep 2024.
Frequently asked questions
Avalon Medicines is an active private limited company based in Sonipat, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 01 November 2022 (4+ years old) and is registered under CIN U24239HR2022PTC107489.
Avalon Medicines has 2 current directors:
- Nitin Chhikara - Director
- Sanjeet Kumar - Director
The latest financial statements of Avalon Medicines on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Avalon Medicines is U24239HR2022PTC107489. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avalon Medicines was incorporated on 01 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Haryana.
The peers of Avalon Medicines by revenue are Fair Ford Pharmaceuticals Private Limited, Gomti Research and Pharmachem Private Limited, Fine Processors Private Limited, Jahnavi Chem Products Private Limited, Emma Trading House India Private Limited and 5 more, all in the same principal business activity (manufacture of basic pharmaceutical products and pharmaceutical preparations).
Aayush Gupta ceased to be Director on 18 Sep 2024. Sanjeet Kumar was appointed as Director on 13 Sep 2024. Nitin Chhikara ceased to be Additional Director on 12 Sep 2024. Avalon Medicines has 5 board changes on record in total.
Yes, Avalon Medicines is registered as an MSME under Udyam registration (number: UDYAM-HR-18-0023878).
The registered office of Avalon Medicines is at 119 Sector 15, Sonipat, Haryana, India – 131001.
Avalon Medicines operates in the pharma industry, in the drug formulation and development segment.
Avalon Medicines has open charges of ₹4 Cr and no satisfied charges on record as per latest MCA filings.

